Is this you?
Request access for Accellacare with your @accellacare.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Accellacare
Unclaimed profileHybrid · Dublin, Ireland (ICON global subsidiary; 50+ sites across 5 countries) · ~50+ sites
Intera lens
ICP 6Lift (cardio sample) 0.09Recruit soph 0.57
Quality Scorecard (1–100)
Overall72Recruit81Ops69Sponsor67Ther67
Performance (observed)
Historical trials
233
Completed
107
Terminated/Withdrawn
20
Completion rate
84%
Active now
106
Phase 2
73
Phase 3
154
Realized enrollment
510,900
First study year
2015
Years active
11
Match confidence
high
Enrollment velocity (inf)
46,445
Therapeutic
Areas
CNS, immune-inflammation, general multi-specialty
Specialties
Multi-specialty: CNS, immune-inflammation, broad therapeutic areas
Breadth (conditions)
201
Languages
Multiple (operates across 6-8 countries)
States
Multiple countries; US presence unclear
Recruitment (web observed)
Trial Finder
Yes
Patient database
Y (8.1M+ patients)
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Y (30+ years, 9,850+ studies completed)
Capability notes
Global site network with patient-centric model; access to 9+ million patients; integrated at-home visit options
Relationships
Sponsors
Novo Nordisk A/S; Pfizer; Eli Lilly and Company; AbbVie; Amgen; BioNTech SE
CROs
ICON Clinical Research; ICON plc; IQVIA Pty Ltd; Premier Research; Rho Federal Systems Division, Inc.
Partnerships
ICON plc (global CRO) subsidiary
Owner / parent
ICON plc (Nasdaq: ICLR) global subsidiary
Funding
ICON plc subsidiary (public enterprise)
Acquisitions
Accellacare is ICON subsidiary
Expansion
Y (50+ sites 5 countries; in-home services global)
Capacity & people
Investigators
—
Coordinators
—
CEO
Barry Balfe (ICON CEO; Accellacare is ICON subsidiary)
VP Clinical Ops
Mohamed Hasham (VP Accellacare Site Network)
VP Site Ops
Ashmee Bharadia (VP Accellacare In-Home Services)
VP Recruitment
Unknown
Emails
Unknown (ICON general contact through website)
Tech & DCT
eSource
Yes
Builds tech
Vendors (ICON platforms)
Home visits
Y (In-Home Services 55+ countries)
DCT / decentralized
Y (in-home services, decentralized model)
Tech stack
CCRPS, web-based platform; Symphony Clinical Research integration for at-home services
Recruiting visible
Unknown
Notes
Global site network with 50+ sites. Strong patient recruitment model with at-home capabilities supporting decentralized trials. ICON backing provides resources. Limited US-focused data in research. International footprint may complicate US-focused enrollment needs.
Recommendation features (sample indication)
Ind fit 0.22Liftability 0.09Overall72
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.